ClinicalTrials.gg
CompletedNCT05933421Updated Sep 21, 2023

A Single Center Retrospective Cohort Study of Auto-intoxicated Patients Admitted to the ICU

An observational study in Intoxication, Depth, sponsored by Jessa Hospital. Completed at 1 site in Belgium. Open to participants aged 14 Years and older. Per ClinicalTrials.gov, last updated 2023-09-21.

Sponsored by Jessa Hospital · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
377
Ages
14 Years and older
Sex
All
01

Study summary

Intentional poisoning is a relevant public health issue responsible for a considerable number of cases of morbidity and mortality worldwide. There are no concrete numbers/investigations of these patients admitted to the ICU at our hospital, with limited insight on their characteristics and outcome.

It is expected that this population of patients is an important burden for the ICU. It can be important to shed a light on prevalence and ratio of intoxicated patients admitted to the ICU in our center.

Furthermore, during the covid-pandemic, we could expect an increase in self-poisoning prevalence due to social restrictions, more limited access to (mental) health care, etc...

Read the detailed description

Aim The aims of this study are to quantify the ratio of intensive care admissions attributable to self-poisoning in our hospital, to examine characteristics and outcome of these patients, yearly trends and impact of the covid-pandemic on these variables.

Design A single center retrospective cohort study analysis of patients with self-poisoning admitted to ICU of the Jessa Hospital Hasselt Belgium over a period of 6 years (2017-2022).

Sample size

All patients diagnosed with self-poisoning admitted to the ICU of the Jessa hospital between 01/01/2017 and 31/12/2022 were included in the study. This were 377 patients.

Study population

Inclusion and exclusion criteria:

All patients (>14 years of age) diagnosed with self-poisoning and admitted to the ICU of the Jessa hospital between 01/01/2017 and 31/12/2022 were included in the study.

Patient admitted for tentamen suicide but not due to intoxication were excluded as well as patients with no medical records in the Jessa hospital.

Primary Outcome The prevalence of auto-intoxicated patients admitted to the ICU together with the mortality rate on the ICU.

Secondary Outcome measurements

Secondary outcome measurement are the ICU and hospital length of stay, ratio of auto-intoxicated patients to all patients admitted at ICU, types of drugs ingested, number of drugs involved, cause of admission, yearly trends and impact of covid-pandemic.

Statistical analysis Data will be presented as mean values +/-SD, numbers(n), and percentages(%) or median (25%, 75% percentile) in case of non-parametric data. Categorical variables are presented as frequencies (%) and groups were compared using Chi-square or Fisher's exact test.

Differences between patients change will be analyzed using the Student t test for continuous outcomes or, in case of non-parametric data, the Mann-Whitney U test. Univariate and multivariate logistic regression models will be used in order to predict mortality. P values \<0.05 will be considered statistically significant.

Additional data collection:

Additional collected parameters are listed below and are collected as a standard-of-care in our hospital:

  • Demographics: i.e age, gender, BMI
  • DNR-code
  • Admission route
  • Patient state and symptoms: i.e vital signs, GCS, ...
  • Comorbidities: i.e smoking, obesity, hypertension, diabetes, cardiovascular disease, respiratory disease, malignancies, renal failure, liver failure, neurological conditions, mental state and disease
  • Technical investigation results: i.e Laboratory results, ECG, radiological findings, etc...
  • Complications: i.e shock, heart failure, sepsis, stroke, etc...
  • Ventilation: method, PEEP, FiO2, P/F ratio,...
  • Management: i.e antidote, supportive, mechanical ventilation, dialysis, observation,
02

Conditions studied

  • Intoxication, Depth
03

In context

Lead sponsor

Jessa Hospital is the lead sponsor of 85 studies on the registry; 14 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
14 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

All patients (>14 years of age) diagnosed with self-poisoning and admitted to the ICU of the Jessa hospital between 01/01/2017 and 31/12/2022 were included in the study.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

All patients (>14 years of age) diagnosed with self-poisoning and admitted to the ICU of the Jessa hospital between 01/01/2017 and 31/12/2022 were included in the study.

Exclusion criteria

Exclusion Criteria:

Patient admitted for tentamen suicide but not due to intoxication were excluded as well as patients with no medical records in the Jessa hospital.

05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
377 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Prevalence of mortality

    The prevalence of auto-intoxicated patients admitted to the ICU together with the mortality rate on the ICU.

    Time frame: patient admitted to the ICU of the Jessa hospital between 01/01/2017 and 31/12/2022

Secondary outcomes

  1. ICU length of stay

    Length of stay in the ICU

    Time frame: patients admitted to the ICU of the Jessa hospital between 01/01/2017 and 31/12/2022

  2. hospital length of stay

    Length of stay in the hospital

    Time frame: patients admitted to the ICU of the Jessa hospital between 01/01/2017 and 31/12/2022

  3. Relative number of auto-intoxicated patients at ICU

    ratio of auto-intoxicated patients to all patients admitted at ICU,

    Time frame: patients admitted to the ICU of the Jessa hospital between 01/01/2017 and 31/12/2022

  4. Type

    type of drugs ingested by patients admitted to ICU

    Time frame: patients admitted to the ICU of the Jessa hospital between 01/01/2017 and 31/12/2022

  5. number of drugs or medication

    number of drugs or medication ingested by patients admitted to ICU

    Time frame: patients admitted to the ICU of the Jessa hospital between 01/01/2017 and 31/12/2022

  6. Cause

    cause of admission to ICU: emotional, relational, somatic, psychological, financial, workrelated, recreative, other or unknown

    Time frame: patients admitted to the ICU of the Jessa hospital between 01/01/2017 and 31/12/2022

  7. Impact of COVID-19 pandemic

    the impact of the COVID-19 pandemic on the number of auto-intoxicated patients admitted to ICU

    Time frame: patients admitted to the ICU of the Jessa hospital between 01/01/2017 and 31/12/2022

07

Study locations

1 site
  • Jessa Hospital
    Hasselt, 3500, Belgium
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Jul 2023 to primary completion in Sep 2023, 2 months.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 28, 2023
First posted
Jul 6, 2023
StartActual
Jul 3, 2023
Primary completionActual
Sep 15, 2023
CompletionActual
Sep 15, 2023
Last update
Sep 21, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 21, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05933421
Lead sponsor
Jessa Hospital
Responsible party
Stessel Björn (Dr, PhD, Jessa Hospital) — Principal investigator
First posted
Jul 6, 2023
Start date
Jul 3, 2023
Primary completion
Sep 15, 2023
Completion
Sep 15, 2023
Last update
Sep 21, 2023

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion